Monogram Orthopaedics, Inc.

NasdaqCM:MGRM Stock Report

Market Cap: US$67.4m

Monogram Orthopaedics Past Earnings Performance

Past criteria checks 0/6

Monogram Orthopaedics's earnings have been declining at an average annual rate of -31.9%, while the Medical Equipment industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 23.3% per year.

Key information

-31.9%

Earnings growth rate

-10.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate23.3%
Return on equity-131.0%
Net Margin-3,669.7%
Next Earnings Update22 May 2024

Recent past performance updates

No updates

Recent updates

Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth?

Mar 21
Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth?

Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Deliver On Growth Plans?

Nov 17
Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Deliver On Growth Plans?

Revenue & Expenses Breakdown
Beta

How Monogram Orthopaedics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:MGRM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 240-13611
31 Dec 230-14711
30 Sep 230-1389
30 Jun 230-1677
31 Mar 230-1356
31 Dec 220-1455
30 Sep 220-1455
30 Jun 220-1365
31 Mar 220-1475
31 Dec 211-1255
30 Sep 211-1045
30 Jun 211-934
31 Mar 210-934
31 Dec 200-925
30 Sep 200-824
30 Jun 200-633
31 Mar 200-422
31 Dec 190-210
30 Sep 190-110
30 Jun 190-110
31 Mar 190-110
31 Dec 180-110

Quality Earnings: MGRM is currently unprofitable.

Growing Profit Margin: MGRM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MGRM is unprofitable, and losses have increased over the past 5 years at a rate of 31.9% per year.

Accelerating Growth: Unable to compare MGRM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MGRM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).


Return on Equity

High ROE: MGRM has a negative Return on Equity (-130.96%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.